Cargando…

The prevalence of type 2 diabetes in South Africa: a systematic review protocol

INTRODUCTION: Type 2 diabetes mellitus is a major source of morbidity and mortality in South Africa, spurred by increased urbanisation and unhealthy lifestyle factors. Local epidemiological data are required to inform health planning and policy. The purpose of this systematic review is to identify,...

Descripción completa

Detalles Bibliográficos
Autores principales: Pheiffer, Carmen, Pillay-van Wyk, Victoria, Joubert, Jané D, Levitt, Naomi, Nglazi, Mweete D, Bradshaw, Debbie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089280/
https://www.ncbi.nlm.nih.gov/pubmed/29997140
http://dx.doi.org/10.1136/bmjopen-2017-021029
_version_ 1783346994698256384
author Pheiffer, Carmen
Pillay-van Wyk, Victoria
Joubert, Jané D
Levitt, Naomi
Nglazi, Mweete D
Bradshaw, Debbie
author_facet Pheiffer, Carmen
Pillay-van Wyk, Victoria
Joubert, Jané D
Levitt, Naomi
Nglazi, Mweete D
Bradshaw, Debbie
author_sort Pheiffer, Carmen
collection PubMed
description INTRODUCTION: Type 2 diabetes mellitus is a major source of morbidity and mortality in South Africa, spurred by increased urbanisation and unhealthy lifestyle factors. Local epidemiological data are required to inform health planning and policy. The purpose of this systematic review is to identify, collate and synthesise all studies reporting the prevalence of diabetes in South Africa. A secondary aim is to report the prevalence of impaired glucose tolerance and impaired fasting glucose, conditions which are associated with an increased risk of progression to overt diabetes, and the prevalence of undiagnosed diabetes. METHODS AND ANALYSIS: Multiple databases will be searched for diabetes prevalence studies conducted in South Africa between 1997 and 2018. Two authors will independently select studies that meet the inclusion criteria, extract data and appraise studies using a risk of bias tool for prevalence studies. Studies with low or moderate risk of bias will be included. Sources of heterogeneity will be explored using subgroup analysis. ETHICS AND DISSEMINATION: The systematic review does not require ethics clearance since published studies with non-identifiable data will be used. This review will provide best estimates to inform the Second National Burden of Disease study which can guide health and policy planning. PROSPERO REGISTRATION NUMBER: CRD42017071280
format Online
Article
Text
id pubmed-6089280
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-60892802018-08-15 The prevalence of type 2 diabetes in South Africa: a systematic review protocol Pheiffer, Carmen Pillay-van Wyk, Victoria Joubert, Jané D Levitt, Naomi Nglazi, Mweete D Bradshaw, Debbie BMJ Open Diabetes and Endocrinology INTRODUCTION: Type 2 diabetes mellitus is a major source of morbidity and mortality in South Africa, spurred by increased urbanisation and unhealthy lifestyle factors. Local epidemiological data are required to inform health planning and policy. The purpose of this systematic review is to identify, collate and synthesise all studies reporting the prevalence of diabetes in South Africa. A secondary aim is to report the prevalence of impaired glucose tolerance and impaired fasting glucose, conditions which are associated with an increased risk of progression to overt diabetes, and the prevalence of undiagnosed diabetes. METHODS AND ANALYSIS: Multiple databases will be searched for diabetes prevalence studies conducted in South Africa between 1997 and 2018. Two authors will independently select studies that meet the inclusion criteria, extract data and appraise studies using a risk of bias tool for prevalence studies. Studies with low or moderate risk of bias will be included. Sources of heterogeneity will be explored using subgroup analysis. ETHICS AND DISSEMINATION: The systematic review does not require ethics clearance since published studies with non-identifiable data will be used. This review will provide best estimates to inform the Second National Burden of Disease study which can guide health and policy planning. PROSPERO REGISTRATION NUMBER: CRD42017071280 BMJ Publishing Group 2018-07-11 /pmc/articles/PMC6089280/ /pubmed/29997140 http://dx.doi.org/10.1136/bmjopen-2017-021029 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Diabetes and Endocrinology
Pheiffer, Carmen
Pillay-van Wyk, Victoria
Joubert, Jané D
Levitt, Naomi
Nglazi, Mweete D
Bradshaw, Debbie
The prevalence of type 2 diabetes in South Africa: a systematic review protocol
title The prevalence of type 2 diabetes in South Africa: a systematic review protocol
title_full The prevalence of type 2 diabetes in South Africa: a systematic review protocol
title_fullStr The prevalence of type 2 diabetes in South Africa: a systematic review protocol
title_full_unstemmed The prevalence of type 2 diabetes in South Africa: a systematic review protocol
title_short The prevalence of type 2 diabetes in South Africa: a systematic review protocol
title_sort prevalence of type 2 diabetes in south africa: a systematic review protocol
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089280/
https://www.ncbi.nlm.nih.gov/pubmed/29997140
http://dx.doi.org/10.1136/bmjopen-2017-021029
work_keys_str_mv AT pheiffercarmen theprevalenceoftype2diabetesinsouthafricaasystematicreviewprotocol
AT pillayvanwykvictoria theprevalenceoftype2diabetesinsouthafricaasystematicreviewprotocol
AT joubertjaned theprevalenceoftype2diabetesinsouthafricaasystematicreviewprotocol
AT levittnaomi theprevalenceoftype2diabetesinsouthafricaasystematicreviewprotocol
AT nglazimweeted theprevalenceoftype2diabetesinsouthafricaasystematicreviewprotocol
AT bradshawdebbie theprevalenceoftype2diabetesinsouthafricaasystematicreviewprotocol
AT pheiffercarmen prevalenceoftype2diabetesinsouthafricaasystematicreviewprotocol
AT pillayvanwykvictoria prevalenceoftype2diabetesinsouthafricaasystematicreviewprotocol
AT joubertjaned prevalenceoftype2diabetesinsouthafricaasystematicreviewprotocol
AT levittnaomi prevalenceoftype2diabetesinsouthafricaasystematicreviewprotocol
AT nglazimweeted prevalenceoftype2diabetesinsouthafricaasystematicreviewprotocol
AT bradshawdebbie prevalenceoftype2diabetesinsouthafricaasystematicreviewprotocol